Copyright
©The Author(s) 2021.
World J Gastrointest Endosc. Dec 16, 2021; 13(12): 628-637
Published online Dec 16, 2021. doi: 10.4253/wjge.v13.i12.628
Published online Dec 16, 2021. doi: 10.4253/wjge.v13.i12.628
Table 1 Strengths and weaknesses of the different strategies for primary prophylaxis of variceal bleeding in cirrhosis
| NSBBs | Carvedilol | EVL | |
| Prevention of mortality | + | +? | +? |
| Prevention of bleeding | + | + | ++ |
| Prevention of other complications of cirrhosis | + | + | - |
| Reduction in HVPG | + | ++ | - |
| Adverse effects | -- | -- | - |
| Serious adverse effects | - | - | -- |
- Citation: de Mattos ÂZ, Terra C, Farias AQ, Bittencourt PL, Alliance of Brazilian Centers for Cirrhosis Care–the ABC Group. Primary prophylaxis of variceal bleeding in patients with cirrhosis: A comparison of different strategies. World J Gastrointest Endosc 2021; 13(12): 628-637
- URL: https://www.wjgnet.com/1948-5190/full/v13/i12/628.htm
- DOI: https://dx.doi.org/10.4253/wjge.v13.i12.628
